Cardio Diagnostics Holdings, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q2 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Cardio Diagnostics Holdings, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q2 2021 to Q1 2024.
  • Cardio Diagnostics Holdings, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $1.58M, a 63.1% decline year-over-year.
  • Cardio Diagnostics Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $3.63M, a 59.9% decline from 2022.
  • Cardio Diagnostics Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $9.06M, a 640% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $1.58M -$2.71M -63.1% Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $4.29M +$4.29M Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $0 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $9.86K Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $34.3K Jun 30, 2021 10-Q 2022-08-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.